Limited Submission: Stimulating Access to Research in Residency (StARR) (R38)


The purpose of this program is to recruit and retain outstanding, postdoctoral-level health professionals who have demonstrated potential and interest in pursuing careers as clinician-investigators. To address the growing need for this critical component of the research workforce, this funding opportunity seeks applications from institutional programs that can provide outstanding mentored research opportunities for Resident-Investigators and foster their ability to transition to individual career development research awards. The program will support institutions to provide support for up to 2 years of research conducted by Resident-Investigators in structured programs for clinician-investigators with defined program milestones.

  • The National Heart, Lung, and Blood Institute (NHLBI) supports a broad research and training portfolio in the treatment and prevention of heart, lung, blood, and sleep diseases and disorders. The NHLBI is tasked with combating not only the major causes of death and disability but also rare disorders such as congenital heart disease, sickle cell disease, thalassemia, and pulmonary fibrosis. The NHLBI’s research programs span the entire research spectrum comprising fundamental discovery science, early translation research, clinical investigations, population science research, and translation research that moves fundamental discoveries into clinical and public health practice in real-world settings.
  • The National Cancer Institute (NCI) supports research in all areas of cancer biology and investigates the biological aspects of every form of cancer, carrying out studies that range from targeted, long-running projects that are revealing the microscopic details of cell processes to high-risk, innovative research that holds promise for providing key insights into tumor development; research in cancer surveillance, epidemiology, health services, behavioral science, and cancer survivorship; research to assess a person’s risk of developing cancer and to find ways to reduce that risk; research focuses across the continuum between the initiation of the cancer process and the occurrence of the invasive disease, with the goal of detecting changes and intervening early in the cancer process to prevent disease and death; research that facilitates the path to clinical application of promising cancer detection, diagnosis, and treatment methods; it also expedites the initial small-scale and subsequent large-scale testing of new anticancer agents, biomarkers, imaging tests, and other therapeutic interventions in patients; cancer health disparities and community-based participatory research; research in HIV/AIDS and HIV malignancies.
  • The National Institute of Allergy and Infectious Diseases (NIAID) conducts and supports basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases. For more than 60 years, NIAID research has led to new therapies, vaccines, diagnostic tests, and other technologies that have improved the health of millions. Specifically, our areas of study are HIV/AIDS, infectious diseases, and allergy, immunology, and transplantation research. Applications for this program would be appropriate for NIAID if they propose research experiences for clinical residents and fellows in the fields of biomedical research (including translational research) in these NIAID mission-relevant areas.

Please read the full program announcement before preparing your internal application.

Award Amount

  • Upper $884,000 USD

The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

The following NIH components intend to commit the following amounts:

  • NHLBI intends to commit total costs of $2,475,000 per year in fiscal years 2018 through 2020 to support up to 7 new awards per fiscal year.
  • NCI intends to commit total costs of $314,000 per year in fiscal years 2018 through 2020 to support one new award per fiscal year.
  • NIAID intends to commit total costs of $3,729,000 to support up to three new awards in fiscal year 2018 only. No new NIAID R38 awards will be made after FY2018.

Institutional award budgets are composed of administrative costs, Resident-Investigator’s salaries, travel, and supplementary research funds, as described below. The institutional program’s annual direct costs must not exceed $221,000.

Awards for institutional programs are for project periods up to four years in duration; an individual Resident-Investigator must be supported for a minimum of one and a maximum of two years.


  • No more than three applications per institution (normally identified by having a unique DUNS number or NIH IPF number) to each participating NIH Institute or Center (IC) per cycle is allowed. No institution will have more than 1 active award at each participating IC.
  • Only graduate medical education residency or fellowship programs recognized by the Accreditation Council for Graduate Medical Education (ACGME) may be included in the proposed program. For Dental Society postgraduate programs, only dental specialties approved by the Council on Dental Education and Licensure of the American Dental Association may be included in the proposed program. For veterinary specialties only specialties recognized by the American Veterinary Medical Association (AVMA) may be included in the proposed program.
  • The Institutional PD/PI(s) should be an established clinician-investigator in a relevant scientific area and capable of providing both administrative and scientific leadership to the development and implementation of the proposed program. The PD/PI(s) must have a regular, full-time appointment (i.e., not adjunct, part-time, or emeritus) at the applicant institution. This person should hold a health professional degree (eg MD, DVM, DDS or equivalents), have an appointment in a clinical department related to at least one of the residency programs proposed for participation, have clearly demonstrated education/mentoring experience and have a strong recent history of NIH funding. Exceptional individuals without a clinical doctorate and with demonstrated leadership and mentoring experience in clinical departments may also serve as PD/PI. If the sponsoring institution is a hospital affiliated with a medical or dental school, the PD/PI must have an appointment in both the medical/dental school and at the sponsoring institution.

Limitation Details

No more than three applications per institution to each participating NIH Institute or Center (IC) per cycle is allowed. If you are interested in applying for this program, you must first submit an internal application to according to the required instructions below.

Internal Applications must include the following:

  • A cover page listing
    • The name of this funding opportunity, title of your proposal, and whether it is a Non-AIDS or AIDS proposal
    • Your name, UGA position, home department, email, and UGA contact information
    • Collaborator names, positions, and institutions (if any)
  • A (maximum two-page) proposal summary
  • One paragraph describing why this proposal should be UGA’s submission (i.e., why it will be the most competitive for this program)
  • PI’s curriculum vitae

Internal Submission Instructions

The above internal application materials should be submitted via email as a single .PDF file to by the internal deadline listed above.


Please submit questions regarding the internal competition to Lauren Sisko at

For questions directly related to this program, please contact the following program officers:

Neil Aggarwal, M.D., Scientific/Research Contact
National Heart Lung and Blood Institute (NHLBI)
Phone: (301) 827-7820

Mark Damico, Ph.D., Scientific/Research Contact
National Cancer Institute (NCI)
Phone: (240) 276-5630

Shawn Gaillard, Ph.D., Scientific/Research Contact
National Institute of Allergy and Infectious Diseases (NIAID)
Phone: (240) 627-3857

Reggie Brown, Financial/Grants Management Contact
National Heart, Lung, and Blood Institute (NHLBI)
Phone: (301) 435-0166

Sean Hine, Financial/Grants Management Contact
National Cancer Institute (NCI)
Phone: (240) 276-6291

Mable Nee, Financial/Grants Management Contact
National Institute of Allergy and Infectious Diseases (NIAID)
Phone: (301) 761-7593

View our calendar for all Current and Closed Limited Submissions.
Subscribe to our listerv to receive weekly internal competition announcements.
What is a
Limited Submission?